MHC class I - Peptide binding and complex stability
Elna Follin
Abstract
Elna Follin
Abstract
The major histocompatibility class I (MHC-I) genes are highly polymorphic and the proteins that they encode play a crucial role in both the innate and the adaptive immune response. A MHC-I molecule consists of three parts, one polymorphic heavy chain, one invariant light chain, β2-microglobulin and a peptide of usually between 8-11 amino acids in length. The maturation and quality control of MHC-I takes place in the endoplasmic reticulum and involves several different proteins including the MHC-I dedicated protein tapasin. In this thesis we have studied different parameters important for MHC-I formation and stability in humans and birds. We have used various approaches including in silico prediction methods, biochemical assays and cellular assays to elucidate the MHC-I maturation. We show that the functional relationships between MHC-I molecules in passerine birds of different species are based on the MHC-I characteristics such as peptide-binding specificity rather than species characteristics. In addition, passerine MHC-I molecules similar to human MHC-I molecules, have a complex dissociation. This suggests that just as in humans, passerine MHC-I molecules go through different maturation stages that most likely include interaction with quality control proteins such as tapasin. The cell surface expression of stable MHC-I molecules is crucial for the function of the adaptive immune response and for this reason MHC-I and its related proteins are often a target for viral and tumour evasion strategies. In human cells we show that tapasin promotes the formation of stable cell surface expressed MHC-I molecules and that the dependency on tapasin for a stable cell surface expression varies between different allomorphs (allele specific protein products). The dysregulation of tapasin results in alterations in the peptide repertoire that is presented by MHC-I at the cell surface and most often this induces a decreased stability of the expressed molecules. We here show that by adding certain peptides exogenously to cells deficient in tapasin we were able to increase MHC-I cell surface stability significantly suggesting that exogenous modulations of tapasin deficient cells might be a possible approach in immunotherapy. The formation of aberrant conformations of HLA-B*27:05 has been suggested to play a role in the pathogenesis of ankylosing spondylitis and here we showed that tapasin has a preventive effect on the formation and presentation of aberrant conformations of HLA-B*27:05 at the cell surface. In conclusion we show that the complex kinetics of MHC-I maturation and stability is a trait shared between birds and humans and we suggest that by studying MHC-I in other species than human we can gain valuable insight into the complex world of MHC-I.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The major histocompatibility class I (MHC-I) genes are highly polymorphic and the proteins that they encode play a crucial role in both the innate and the adaptive immune response. A MHC-I molecule consists of three parts, one polymorphic heavy chain, one invariant light chain, β2-microglobulin and a peptide of usually between 8-11 amino acids in length. The maturation and quality control of MHC-I takes place in the endoplasmic reticulum and involves several different proteins including the MHC-I dedicated protein tapasin. In this thesis we have studied different parameters important for MHC-I formation and stability in humans and birds. We have used various approaches including in silico prediction methods, biochemical assays and cellular assays to elucidate the MHC-I maturation. We show that the functional relationships between MHC-I molecules in passerine birds of different species are based on the MHC-I characteristics such as peptide-binding specificity rather than species characteristics. In addition, passerine MHC-I molecules similar to human MHC-I molecules, have a complex dissociation. This suggests that just as in humans, passerine MHC-I molecules go through different maturation stages that most likely include interaction with quality control proteins such as tapasin. The cell surface expression of stable MHC-I molecules is crucial for the function of the adaptive immune response and for this reason MHC-I and its related proteins are often a target for viral and tumour evasion strategies. In human cells we show that tapasin promotes the formation of stable cell surface expressed MHC-I molecules and that the dependency on tapasin for a stable cell surface expression varies between different allomorphs (allele specific protein products). The dysregulation of tapasin results in alterations in the peptide repertoire that is presented by MHC-I at the cell surface and most often this induces a decreased stability of the expressed molecules. We here show that by adding certain peptides exogenously to cells deficient in tapasin we were able to increase MHC-I cell surface stability significantly suggesting that exogenous modulations of tapasin deficient cells might be a possible approach in immunotherapy. The formation of aberrant conformations of HLA-B*27:05 has been suggested to play a role in the pathogenesis of ankylosing spondylitis and here we showed that tapasin has a preventive effect on the formation and presentation of aberrant conformations of HLA-B*27:05 at the cell surface. In conclusion we show that the complex kinetics of MHC-I maturation and stability is a trait shared between birds and humans and we suggest that by studying MHC-I in other species than human we can gain valuable insight into the complex world of MHC-I.
Key concepts: MHC class I, Major histocompatibility complex, Biology, Transporter associated with antigen processing, MHC restriction, CD74, Cell biology, Immune system